Clinical Trial Update: Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial [NA]

View source ↗

Summary

A multicenter randomized trial is evaluating whether MULTIplex PCR, procalcitonin testing, and sputum appearance can shorten antibiotic duration during severe C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Exacerbation of COPD | NA | Status: RECRUITING